Similar sex differences, characterized by higher peripheral blood GFAP levels in females, have also been described in Alzheimer's disease [34], Parkinson's disease [35], and in traumatic brain injury [36]. This evidence concerns the gene GFAP and early-onset autosomal dominant Alzheimer disease.